Login / Signup

Pharmacokinetics studies of 4'-cyano-2'-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats.

Mai HashimotoKazuaki TaguchiTakako IshiguroSatoru KohgoShuhei ImotoKeishi YamasakiHiroaki MitsuyaMasaki Otagiri
Published in: The Journal of pharmacy and pharmacology (2018)
The data generated in this study provide support for the clinical development of CdG for use in the treatment of HBV.
Keyphrases
  • hepatitis b virus
  • liver failure
  • electronic health record
  • big data
  • machine learning
  • combination therapy
  • anti inflammatory
  • artificial intelligence